NCT04886024

Evaluation of Serum Ages Levels in Patients With Endometriosis

The Serum Ages Levels in Patients With Endometriosis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 90 (actual)
• Sponsor: Kanuni Sultan Suleyman Training and Research Hospital · Academic / Other
• Sex: Female
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

Serum AGES (Advanced Glycation End Products) levels of endometriosis patients are compared with a group of healthy volunteers of the same age.

Detailed description

Serum AGES (Advanced Glycation End Products) levels are compared with 45 endometriosis patients and 45 healthy volunteers of the same age. The energy metabolism of the endometriosis group and its possible relationship with the endometriosis stage will be compared since AGES (Advanced Glycation End Products) gives information about the energy metabolism of the people.

Conditions

• Endometriosis

Interventions

Type	Name	Description
OTHER	Advanced Glycation End Products (AGEs)	Advanced Glycation End Products (AGEs) releated with energy metabolism, In this study, the possible relationship between the serum levels of Advanced Glycation End Products (AGEs) of endometriosis patients and the disease and its stage is evaluated.

Timeline

• Start date: 2020-12-05
• Primary completion: 2021-07-20
• Completion: 2021-07-30
• First posted: 2021-05-13
• Last updated: 2021-08-31

Locations

1 site across 1 country: Turkey (Türkiye)